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Conclusion: Identiﬁcation of a population of carriers of
Salmonella spp. in an endemic region would provide evidence for
a targeted means of transmission containment and prevention,
including sensibilization and sanitation enforcement followed by
potential vaccination of at-risk populations.
http://dx.doi.org/10.1016/j.ijid.2014.03.943
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Background:Hypothesis:Massdrugadministration (MDA)will
be an effective public health measure to reduce the prevalence of
scabies and strongyloidiasis in a remote Aboriginal community in
Australia where both parasitic infections are endemic.
Methods & Materials: A population census and MDA was
conducted in 2010 and 2011 to screen participants for scabies
and strongyloidiasis and administer medications. Scabies was
diagnosed clinically, strongyloidiasis serologically or from copro-
ligcal examination. Participants were administered a stat dose of
200g/kg ivermectin unless their weight was <15kg or pregnant.
Participants diagnosed with scabies and/or strongyloidiasis were
given a 2nd treatment 2-3 weeks after the ﬁrst medications were
administered.
Two cross sectional surveys were conducted 6 months after
the MDA to follow-up participants who had been diagnosed with
scabies and/or strongyloidiasis to determine treatment failures.
Disease acquisition was measured from a sample of participants
who had no scabies or strongyloidiasis at the population census 6
months prior.
Results: At the population census and MDA in 2010, 1012 (80%)
participants were screened from 127 (80%) houses in the remote
community and 7 surrounding homelands. Scabies prevalence was
4% and strongyloidiasis was 21%. In 2011, 1060 participants were
screened, 702 that had been seen previously and 358 new entries.
The prevalence of scabies increased to 9% for participants seen pre-
viously with strongyloidiasis prevalence decreasing to 6%.
At the cross sectional surveys, 80% of participantswere followed
up. The treatment failures remained constant at 6% (2010) and
7% (2011) for scabies increasing slightly but not signiﬁcantly from
17% (2010) to 23% (2011) for strongyloidiasis. Scabies acquisition
increased but not signiﬁcantly from 3% (2010) to 8% (2011) and
decreased from 4% (2010) to 1% (2011) for strongyloidiasis. Scabies
prevalence decreased signiﬁcantly at both cross sectional surveys
from 4% to 1% in 2010 and 9% to 2% in 2011. Strongyloidiasis preva-
lence decreased signiﬁcantly from 21% to 6% which was sustained
for the duration of the project.
Conclusion: Scabies and strongyloidiasis are neglected tropical
diseases that contribute to the signiﬁcantmorbidity experiencedby
Australian Aboriginals in remote communities. MDA is an effective
public health measure to reduce the prevalence of both parasitic
infections.
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Measles-mumps-rubeola (MMR), varicella, and
hepatitis A (HAV) seroprevalances among
healthcare workers and their compliance to
vaccination
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Background: In this study, we aimed to determine theMeasles-
Mumps- Rubeola (MMR), Varicella, and Hepatitis A (HAV) sero-
prevalences among the healthcare workers (HCWs) and also their
compliance to vaccination.
Methods & Materials: The health records of 5040 HCWs, who
admitted to the Vaccination Clinic for HCWs, were evaluated retro-
spectively. Seropositivity rates to MMR, Varicella, and HAV were
calculated, HCWs’ compliance to the vaccinations were investi-
gated. Statistical package SPSS version 15 was used to conduct
analysis.
Results: The HAV, MMR and Varicella seropositivity rates,
among the HCWs, were 70, 6%, 81, 5%, 83, 8%, 94, 7% and 95, 2%,
respectively. Anti-HAV positivity was found higher in nurses and
doctors than the nursing andmedical students (p <0,001). Seropos-
itivity rate to measles was found lower in students, young and
female personnel (p <0, 01). No association was found between a
history of infection and the seropositivity (Table 1). Compliance
rates to vaccination were found between 33, 5% and 63, 3%. Com-
pliance was higher in females, younger than 20 years, and students
(p <0,001).
Conclusion: In the past, HAV seropositivity rates among HCWs
were reported higher than the community (90, 4%-99, 5% vs. 40%-
80, 8%) in Turkey. In our study, HAV seropositivity (70, 6%) was not
founddifferent fromthecommunity’s rates. This couldbeexplained
with the improvement in the condition of hygiene in the commu-
Table 1
HCWs’ history of illness and seropositivity due to the infection.
Infection (Total Number) Seropositivity (%) History of illness (%)*
Yes No
Rubella (2451) 2321 (94,7) 100 97,7
Measles (1558) 1269 (81,5) 93,3 92,6
Mumps (1010) 846 (83,8) 90,7 69,2
Varicella (852) 811 (95,2) 100 95,2
*Seropositivity rates due to the history of illness.
